On May 16, 2016, GENESIS obtained New Drug and Production Approval of CFDA for Mycoplasma Pneumoniae Antigen Rapid Diagnostic Test Kit.
GENESIS' paper,Scientific Reports:Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immunochromatographic antigen assay.
T.B. Identification kit and M. P. Antigen Test Kit are the two“only-one” available products in China.